179 related articles for article (PubMed ID: 33269655)
41. Counterintuitive Pulmonary Nodules in Rheumatoid Arthritis.
Zamora FD; Podgaetz E; Dincer HE
Arch Bronconeumol; 2016 Jun; 52(6):334-5. PubMed ID: 26818558
[No Abstract] [Full Text] [Related]
42. Leukocytapheresis for rheumatoid arthritis cases that are super-resistant to any class of biological drugs and tofacitinib.
Mori S
Transfus Apher Sci; 2020 Dec; 59(6):102920. PubMed ID: 32896492
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Int J Rheum Dis; 2020 Jul; 23(7):868-875. PubMed ID: 32483919
[TBL] [Abstract][Full Text] [Related]
44. Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021.
Li X; Pathadka S; Man KK; Wong ICK; Chan EWY
Hong Kong Med J; 2019 Jun; 25(3):201-208. PubMed ID: 31178440
[TBL] [Abstract][Full Text] [Related]
45. Rheumatoid arthritis with diffuse pulmonary rheumatoid nodules.
Kitamura A; Matsuno T; Narita M; Shimokata K; Yamashita Y; Mori N
Pathol Int; 2004 Oct; 54(10):798-802. PubMed ID: 15482571
[TBL] [Abstract][Full Text] [Related]
46. Successful treatment of rheumatoid neutrophilic panniculitis with tofacitinib.
Almeida Junior HL; Furtado VD; Issaacson VS; Boff AL
An Bras Dermatol; 2024; 99(4):644-647. PubMed ID: 38658238
[No Abstract] [Full Text] [Related]
47. Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib.
Shovman O; Gilburd B; Watad A; Amital H; Langevitz P; Bragazzi NL; Adawi M; Perez D; Lidar M; Katz I; Blank M; Biln NK; Marotta A; Shoenfeld Y
Pharmacol Res; 2019 Mar; 141():623-626. PubMed ID: 30414892
[TBL] [Abstract][Full Text] [Related]
48. Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy.
Rozin A; Yigla M; Guralnik L; Keidar Z; Vlodavsky E; Rozenbaum M; Nahir AM; Balbir-Gurman A
Clin Rheumatol; 2006 May; 25(3):384-8. PubMed ID: 16211338
[TBL] [Abstract][Full Text] [Related]
49. Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis.
Cohen S; Radominski SC; Gomez-Reino JJ; Wang L; Krishnaswami S; Wood SP; Soma K; Nduaka CI; Kwok K; Valdez H; Benda B; Riese R
Arthritis Rheumatol; 2014 Nov; 66(11):2924-37. PubMed ID: 25047021
[TBL] [Abstract][Full Text] [Related]
50. Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment.
Kim J; Tomalin L; Lee J; Fitz LJ; Berstein G; Correa-da Rosa J; Garcet S; Lowes MA; Valdez H; Wolk R; Suarez-Farinas M; Krueger JG
J Invest Dermatol; 2018 Feb; 138(2):273-281. PubMed ID: 28927890
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation.
Koga T; Sato T; Umeda M; Fukui S; Horai Y; Kawashiri SY; Iwamoto N; Ichinose K; Nakamura H; Kawakami A
Clin Immunol; 2016 Dec; 173():147-148. PubMed ID: 27720846
[No Abstract] [Full Text] [Related]
52. Varicella zoster virus myelitis in a patient with rheumatoid arthritis treated by tofacitinib.
Itamiya T; Komai T; Tsuchida Y; Shoda H; Fujio K
Scand J Rheumatol; 2021 Jul; 50(4):319-321. PubMed ID: 32940139
[No Abstract] [Full Text] [Related]
53. A case report of extra-articular manifestation of rheumatoid arthritis: Rheumatoid nodules in lungs.
Bektyrganova S; Kozhakhmet D; Kim A; Baigenzhin A; Togizbayev G; Doszhan A; Krivoruchkо N; Pak A; Peradze M; Sarsengaliyev T
Int J Rheum Dis; 2024 Jan; 27(1):e14904. PubMed ID: 37784218
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary rheumatoid nodules: presentation, methods, diagnosis and progression in reference to 5 cases.
Gómez Herrero H; Arraiza Sarasa M; Rubio Marco I; García de Eulate Martín-Moro I
Reumatol Clin; 2012; 8(4):212-5. PubMed ID: 22265461
[TBL] [Abstract][Full Text] [Related]
55. Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib.
Charles-Schoeman C; Fleischmann R; Davignon J; Schwartz H; Turner SM; Beysen C; Milad M; Hellerstein MK; Luo Z; Kaplan IV; Riese R; Zuckerman A; McInnes IB
Arthritis Rheumatol; 2015 Mar; 67(3):616-25. PubMed ID: 25470338
[TBL] [Abstract][Full Text] [Related]
56. First use of tofacitinib to treat an immune checkpoint inhibitor-induced arthritis.
Murray K; Floudas A; Murray C; Fabre A; Crown J; Fearon U; Veale D
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33541985
[TBL] [Abstract][Full Text] [Related]
57. A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis.
Bannwarth B; Kostine M; Poursac N
Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):753-61. PubMed ID: 23570265
[TBL] [Abstract][Full Text] [Related]
58. Tofacitinib citrate-based liposomes for effective treatment of rheumatoid arthritis.
Shen Q; Shu H; Xu X; Shu G; Du Y; Ying X
Pharmazie; 2020 Apr; 75(4):131-135. PubMed ID: 32295688
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R; Mysler E; Hall S; Kivitz AJ; Moots RJ; Luo Z; DeMasi R; Soma K; Zhang R; Takiya L; Tatulych S; Mojcik C; Krishnaswami S; Menon S; Smolen JS;
Lancet; 2017 Jul; 390(10093):457-468. PubMed ID: 28629665
[TBL] [Abstract][Full Text] [Related]
60. Intrapulmonary rheumatoid nodules in a patient with long-standing rheumatoid arthritis treated with leflunomide.
Horvath IF; Szanto A; Csiki Z; Szodoray P; Zeher M
Pathol Oncol Res; 2008 Mar; 14(1):101-4. PubMed ID: 18392955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
